Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dynal Biotech is a pioneering life sciences company best known for developing and commercializing Dynabeads, the first uniform superparamagnetic beads used for biological separation. The company's technology revolutionized the isolation of cells, proteins, and nucleic acids, providing a rapid and reliable method for research and diagnostic applications. Originally founded in Norway based on the inventions of Professor John Ugelstad, Dynal's products became the gold standard in immunomagnetic separation. These tools are now widely used in clinical diagnostics, molecular biology, and the manufacturing of advanced cell therapies like CAR-T. Following its acquisition by Invitrogen in 2005, the company was integrated into what is now Thermo Fisher Scientific, where the Dynal brand remains a market leader in magnetic bead-based solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dynal Biotech.